Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 18k
18 April 2019
E-002003-19
Question for written answer E-002003-19
to the Commission
Rule 130
Nicola Caputo (S&D)

 Subject:  HPV and cardiovascular diseases
 Answer in writing 

A comprehensive study by the American Heart Association has shown that the feared Papillomavirus (HPV), already associated with certain types of cancer, might also increase the risk of heart disease, particularly in the case of women infected with the virus.

The study involved 63 411 women aged 30 or over with no history of cardiovascular disease. It was observed that the women who had high-risk HPV infections (7% of the cohort), were 22% more likely to develop the above diseases than uninfected women. The chances of this were even greater, in certain cases twice as high, where high-risk HPV occurred in conjunction with obesity and/or metabolic syndrome.

In view of this:
1. Can the Commission say whether it has detailed information regarding this matter?
2. What action will it take to improve HPV prevention strategies?
Original language of question: IT 
Last updated: 2 May 2019Legal notice